Overview

A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis

Status:
NOT_YET_RECRUITING

Trial end date:
2026-12-09

Target enrollment:

Participant gender:

Summary

This study has been designed to explore the clinical efficacy and safety of HS-10374 in the treatment of mild-to-moderate plaque psoriasis.

Phase:

PHASE2

Details

Lead Sponsor:

Hansoh BioMedical R&D Company